Post-fracture management of patients with hip fracture: A perspective

Current Medical Research and Opinion

Volumn 24, Issue 10, 2008, Pages 2841-2851

  Bruyere, Olivier ^a   Brandi, M L ^b   Burlet, N ^c   Harvey, N ^d   Lyritis, G ^e   Minne, H ^f   Boonen, S ^g   Reginster, J Y ^h   Rizzoli, R ⁱ   Akesson, K ^j  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF FLORENCE   (Italy)

^c International Osteoporosis Foundation Switzerland   (Switzerland)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e KAT HOSPITAL   (Greece)

^f Institute of Clinical Osteology   (Germany)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h UNIVERSITY OF LIÈGE   (Belgium)

ⁱ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Hip fracture; Optimal management; Postoperative care; Rehabilitation

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLLAGEN TYPE 1; IBANDRONIC ACID; PARATHYROID HORMONE; PLACEBO; PROTEIN; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STRONTIUM RANELATE; VITAMIN D; VITAMIN D RECEPTOR; ZOLEDRONIC ACID;

ARTICLE; BODY EQUILIBRIUM; BONE DENSITY; BONE MINERAL; BONE NECROSIS; BONE REMODELING; CLINICAL PATHWAY; CLINICAL TRIAL; COST OF ILLNESS; DETERIORATION; DIET SUPPLEMENTATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FALLING; GENETIC RISK; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEREDITY; HIGH RISK PATIENT; HIP FRACTURE; HIP SURGERY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPOCALCEMIA; INCIDENCE; INFORMATION RETRIEVAL; JAW DISEASE; LOADING DRUG DOSE; MALNUTRITION; MEDLINE; MUSCLE STRENGTH; NONHUMAN; OSTEOPOROSIS; PATIENT EDUCATION; PATIENT MOBILITY; PERIOPERATIVE PERIOD; PHYSIOTHERAPY; POSTMENOPAUSE OSTEOPOROSIS; POSTOPERATIVE CARE; PRIMARY PREVENTION; QUALITY OF LIFE; REHABILITATION CARE; RISK REDUCTION; SURVIVAL RATE; TEAMWORK; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION; WALKING AID;

EID: 55549141193     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802381430     Document Type: Article

References (87)

1. Cooper C. The crippling consequences of fractures and their impact on quality of life. Am J Med 1997;103:12-17S
2. Wolinsky FD, Fitzgerald JF, Stump TE. The effect of hip fracture on mortality, hospitalization and functional status: a prospective study. Am J Public Health 1997;87:398-403
3. Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000;15:721-39
4. Schürch MA, Rizzoli R, Mermillod B, et al. A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res 1996;11:1935-42
5. Trombetti A, Herrmann F, Hoffmeyer P, et al. Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 2002;13:731-7
6. Kanis JA, Johnell O, on behalf of the Committee of Scientific Advisors of the International Osteoporosis Foundation. Requirements for DYA for the management of osteoporosis in Europe. Osteoporos Int 2005;16:220-38
7. Cooper C, Campion G, Melton 3rd U. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992;2:285-9
8. Cooper C, Atkinson EJ, Jacobsen SJ, et al. Population-based study of survival after osteoporotic fractures. Am J Epidemiol 1993;137:1001-5
9. Autier P, Haentjens P, Bentin J, et al. Costs induced by hip fractures: a prospective controlled study in Belgium. Belgian Hip Fracture Study Group. Osteoporos Int 2000;11:373-80
10. Haentjens P, Autier P, Barette M, et al. The economic cost of hip fractures among elderly women. A one-year, prospective, observational cohort study with matched-pair analysis. Belgian Hip Fracture Study Group. J Bone Joint Surg Am 2001;83:493-500
11. Zethraeus N, Ben Sedrine W, Caulin F, et al. Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis. Osteoporos Int 2002;13:841-57
12. Boonen S, Autier P, Barette M, et al. Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int 2004;15:87-94
13. Harvey N, Dennison E, Cooper C. The epidemiology of osteoporosis. Osteoporosis Rev 2005;13:1-6
14. van Staa TP, Dennison EM, Leufkens HG, et al. Epidemiology of fractures in England and Wales. Bone 2001;29:517-22
15. Kanis JA, Johnell O, De Laet C, et al. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 2002;17:1237-44
16. Vestergaard P, Rejnmark L, Mosekilde L. Socioeconomic aspects of fracture within universal public healthcare: a nationwide case-control study from Denmark. Scand J Public Health 2006;34:371-7.
17. Holmberg AH, Johnell O, Nilsson PM, et al. Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and women. Osteoporos Int 2005;16:2185-94
18. Chevalley T, Guilley E, Herrmann F, et al. First hip fracture risk is higher and occurs at an earlier age in communities with low income. Osteoporos Int 2008;19:29-207 (Abstr)
19. Kanis JA, Borgstrom F, de Laet C, et al. Assessment of future risk. Osteoporos Int 2005;16:581-9
20. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-97
21. Faulkner KG, Cummings SR, Black D, et al. Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res 1993;8:1211-17
22. Flicker L, Faulkner KG, Hopper JL, et al. Determinants of hip axis length in women aged 10-89 years: a twin study. Bone 1996;18:41-5
23. Michaëlsson K, Melhus H, Ferm H, et al. Genetic liability to fractures in the elderly. Arch Intern Med 2005;165:1825-30
24. Sun Q, Turner CH. Two inbred rat strains that differ substantially in hip fragility. Calcif Tissue Int 2003;72:498-504
25. Volkman SK, Galecki AT, Burke DT, et al. Quantitative trait loci for femoral size and shape in a genetically heterogeneous mouse population. J Bone Miner Res 2003;18:1497-505
26. Kellie SE, Brody JA: Sex-specific and race specific hip fracture rates. Am J Public Health. 1990;80:326-8
27. Nelson DA, Jacobsen G, Barondess DA, et al. Ethnic differences in regional bone density, hip axis length, and lifestyle variables among healthy black and white men. J Bone Miner Res 1995;10:782-7
28. Yan L, Zhou B, Prentice A, et al. Epidemiological study of hip fracture in Shenyang, People's Republic of China. Bone 1999;24:151-5
29. Yan L. Does hip strength analysis explain the lower incidence of hip fracture in the People's Republic of China? Bone 2004;34:584-8
30. Graafmans WC, Lips P, Ooms ME, et al. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res 1997;12:1241-5
31. Beavan S, Prentice A, Dibba B, et al. Polymorphism of the collagen type Ialphal gene and ethnic differences in hip-fracture rates. N Engl J Med 1998;339:351-2
32. Cauley JA, Zmuda, JM, Yaffe K, et al. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk - the study of osteoporotic fractures. J Bone Miner Res 1999;14:1175-81
33. Shen H, Long J-R, Xiong D-H, et al. Mapping quantitative trait loci for cross-sectional geometry at the femoral neck. J Bone Miner Res 2005;20:1973-82
34. Foss NB, Kristensen MT, Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Ageing 2008;37:173-8
35. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535-41
36. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-40
37. Silverman SL, Watts NB, Delmas PD, et al. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int 2007;18:25-34
38. Reginster JY, Blumentals W, Barr C, et al. Fracture efficacy of monthly ibandronate and weekly bisphosphonate therapy: a retrospective cohort study. Osteoporos Int 2008;19:S9
39. Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809-22
40. Meunier PJ, Reginster JY. Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis. Osteoporos Int 2003;14(Suppl 3):66-73
41. Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: TReatment of Peripheral OSteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005;90:2816-22
42. Reginster JY, Felsenberg D, Boonen S, et al. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum 2008;58:1687-95
43. Colón-Emeric C, Kuchibhatla M, Pieper C, et al. The contribution of hip fracture to risk of subsequent fracture: data from two longitudinal studies. Osteoporos Int 2003;14:879-83
44. Gardner MJ, Brophy RH, Demetrakopoulos D, et al. Interventions to improve osteoporosis treatment following hip fracture: a prospective, randomized trial. J Bone Joint Surg Am 2005;87:3-7
45. Solomon DH, Finkelstein JS, Katz JH, et al. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med 2003;115:398-400
46. Colón-Emeric CS, Lyles KW, House P, et al. Randomized trial to improve fracture prevention in nursing home residents. Am J Med 2007;120:886-92
47. Boonen S, Rosen C, Bouillon R, et al. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab 2002;87:1593-9
48. Lyles KW, Colón-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007;357:1799-809
49. Guigoz Y, Vellas B, Garry PJ. Mini Nutritional Assessment: a practical assessment tool for grading the nutritional state of elderly patients. Facts and Research in Gerontology. 1994;(Suppl 2):15-59
50. Reuben DB, Greendale GA, Harrison GG. Nutrition screening in older persons. J Am Geriatr Soc 1995;43:415-25
51. Rubenstein LZ, Harker J, Guigoz Y, et al. Comprehensive geriatric assessment (CGA) and the MNA: an overview of CGA, nutritional assessment, and development of a shortened version of the MNA. In: Vellas B, Garry PJ, Guigoz Y. Mini Nutritional Assessment (MNA): Research and Practice in the Elderly. Nestlé Workshop Series Clinical & Performance Programme, Vol 1. Basel: Nestlé, 1999:101-16
52. Bischoff-Ferrari HA, Can U, Staehelin HB, et al. Severe vitamin D deficiency in Swiss hip fracture patients. Bone 2008;42:597-602
53. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am J Clin Nutr 2004;80:752-8
54. Leboff MS, Hawkes WG, Glowacki J, et al. Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int 2008 Mar 29 [Epub ahead of print]
55. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006
56. Bischoff-Ferrari HA, Orav JE, Barrett JA, et al. Effect of seasonality and weather on fracture risk in individuals 65 years and older. Osteoporos Int 2007;18:1225-33
57. Boonen S, Vanderschueren D, Haentjens P, et al. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. J Intern Med 2006;259:539-52
58. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007;92:1415-23
59. Rizzoli R, Ammann P, Chevalley T, et al. Protein intake and bone disorders in the elderly. Joint Bone Spine 2001;68:383-92
60. Schürch MA, Rizzoli R, Slosman D, et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998; 128:801-9
61. Chevalley T, Hoffmeyer P, Bonjour JP, et al. Early response of serum IGF-1 to oral protein supplements in elderly women with a recent hip fracture. J Nutr Health Aging 2006;10:347
62. Tkatch L, Rapin CH, Rizzoli R, et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. J Am Coll Nutr 1992;11:519-25
63. Alegre-López J, Cordero-Guevara J, Alonso-Valdivielso JL, et al. Factors associated with mortality and functional disability after hip fracture: an inception cohort study. Osteoporos Int 2005;16:729-36
64. Williams CS, Tinetti ME, Kasl SV, et al. The role of pain in the recovery of instrumental and social functioning after hip fracture. J Aging Health 2006;18:743-62
65. Geusens P, Autier P, Boonen S, et al. The relationship among history of falls, osteoporosis, and fractures in postmenopausal women. Arch Phys Med Rehabil 2002;83:903-6
66. Oude Voshaar RC, Banerjee S, Horan M, et al. Fear of falling more important than pain and depression for functional recovery after surgery for hip fracture in older people. Psychol Med 2006;36:1635-45
67. Nevitt MC, Cummings SR, Hodes ES. Risk factors for injurious falls: a prospective study. J Gerontol 1991;5:164-70
68. Yardley L, Beyer N, Hauer K, et al. Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing 2005;34:614-19
69. Kristensen MT, Foss NB, Kehlet H. Timed 'Up & Go' Test as a predictor of falls within 6 months after hip fracture surgery. Phys Ther 2007;87:24-30
70. Sjösten NM, Salonoja M, Piirtola M, et al. A multifactorial fall prevention programme in home-dwelling elderly people: a randomized-controlled trial. Public Health 2007;121:308-18
71. Campbell AJ, Robertson MC, Gardner MM, et al. Falls prevention over 2 years: a randomized controlled trial in women 80 years and older. Age Ageing 1999;28:513-18
72. Skelton DA, Dinan SM, Campbell M, et al. FaME (Falls Management Exercise): an RCT on the effects of a 9-month group exercise programme in frequently falling community dwelling women age 65 and over. J Aging Phys Act 2004;12:457-8
73. Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000;15:1113-18
74. Runge M, Schacht E. Multifactorial pathogenesis of falls as a basis for multifactorial interventions. J Musculoskelet Neuronal Interact 2005;5:127-34
75. Dukas L, Bischoff HA, Lindpaintner LS, et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc 2004;52:230-6
76. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on failing in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 2006;166:424-30
77. Becker C, Kron M, Lindemann U, et al. Effectiveness of a multifaceted intervention on falls in nursing home residents. J Am Geriatr Soc 2003;51:306-13
78. Jensen J, Nyberg L, Rosendahl E, et al. Effects of a fall prevention program including exercise on mobility and falls in frail older people living in residential care facilities. Aging Clin Exp Res 2004;16:283-92
79. Bruyere O, Wuidart MA, Di Palma E, et al. Controlled whole body vibration to decrease fall risk and improve health-related quality of life of nursing home residents. Arch Phys Med Rehabil 2005;86:303-7
80. Vidán M, Serra JA, Moreno C, et al. Efficacy of a comprehensive geriatric intervention in older patients hospitalized for hip fracture: a randomized, controlled trial. J Am Geriatr Soc 2005;53:1476-82
81. Mendelsohn ME, Overend TJ, Connelly DM, et al. Improvement in aerobic fitness during rehabilitation after hip fracture. Arch Phys Med Rehabil 2008;89:609-17
82. Oldmeadow LB, Edwards ER, Kimmel LA, et al. No rest for the wounded: early ambulation after hip surgery accelerates recovery. ANZ J Surg 2006;76:607-11
83. Handoll, HH, Sherrington, C. Cochrane Database of Systematic Reviews (online) (1) CD 001704 (2007)
84. Gehlbach SH, Bigelow C, Heimisdottir M, et al. Recognition of vertebral fracture in a clinical setting. Osteoporos Int 2000;11:577-82
85. Andrade SE, Majumdar SR, Chan KA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003; 163:2052-7
86. Chevalley T, Hoffmeyer P, Bonjour JP, et al. An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int 2002;13:450-5
87. McLellan AR, Gallacher SJ, Fraser M, et al. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 2003;14:1028-34